Age, Biography and Wiki

Gerardo Turcatti was born on 1959 in Montevideo, Uruguay. Discover Gerardo Turcatti's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of networth at the age of 64 years old?

Popular As N/A
Occupation N/A
Age 64 years old
Zodiac Sign
Born 1959, 1959
Birthday 1959
Birthplace Montevideo, Uruguay
Nationality Uruguay

We recommend you to check the complete list of Famous People born on 1959. He is a member of famous with the age 64 years old group.

Gerardo Turcatti Height, Weight & Measurements

At 64 years old, Gerardo Turcatti height not available right now. We will update Gerardo Turcatti's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.

Parents Not Available
Wife Not Available
Sibling Not Available
Children Not Available

Gerardo Turcatti Net Worth

His net worth has been growing significantly in 2022-2023. So, how much is Gerardo Turcatti worth at the age of 64 years old? Gerardo Turcatti’s income source is mostly from being a successful . He is from Uruguay. We have estimated Gerardo Turcatti's net worth , money, salary, income, and assets.

Net Worth in 2023 $1 Million - $5 Million
Salary in 2023 Under Review
Net Worth in 2022 Pending
Salary in 2022 Under Review
House Not Available
Cars Not Available
Source of Income

Gerardo Turcatti Social Network




In 2006, after a 20 year career in biotechnology and pharmaceutical companies, he founded the Biomolecular Screening Facility (BSF) at EPFL and has been its director since its inception. In 2020, Turcatti became Adjunct Professor at EPFL. In the framework of the NCCR research project on chemical biology, he is the project leader of the Swiss academic platform for chemical screens (ACCESS project).


As a spin-off of Serono, in January 2001, he co-founded Manteia Predictive Medicine and became executive technology director. The Swiss-based company invented and developed novel high throughput DNA sequencing technologies currently owned by Illumina.


Until 1997 he was a research scientist at the Biochemistry Department of the Glaxo Wellcome Biomedical Research Institute, where he further adapted the methodologies he developed during his PhD to other G protein-coupled receptors (GPCR). In 1998 he went to work as a senior scientist at the Genomic Technologies Department of the Serono Pharmaceutical Research Institute.


Turcatti studied chemistry at the University of the Republic in Uruguay. In 1981, he moved to Switzerland to earn a Master's degree in chemical engineering from the University of Geneva. Discovering the world of life sciences while working at the biotech company Biogen during his studies, he pursued a career as a chemical biologist. While working at the Glaxo Biomedical Research Institute in Geneva, he studied under Professor Horst Vogel at EPFL for an industry PhD thesis in chemistry and biochemistry titled "Novel fluorescence-based approaches to probe ligand recognition and structure of the tachykinin NK2 receptor". His thesis earned him the EPFL Doctorate Award in 1996.


Gerardo Turcatti (born 1959 in Montevideo, Uruguay) is a Swiss-Uruguayan chemist who specialises in chemical biology and drug discovery. He is a professor at the École Polytechnique Fédérale de Lausanne (EPFL) and director of the Biomolecular Screening Facility at the School of Life Sciences there.